A review on evaluation of technetium-99m labeled radiopharmaceuticals

MU Akbar, MR Ahmad, A Shaheen… - Journal of Radioanalytical …, 2016 - Springer
In the past few years, substantial progress has been made in technetium chemistry,
including the synthesis of a variety of 99m Tc-radiopharmaceuticals. This synthesis can be …

An overview of bioactive peptides for in vivo imaging and therapy in human diseases

A Lucia Tornesello, M Lina Tornesello… - Mini reviews in …, 2017 - benthamdirect.com
Background: Radiolabeled peptides, designed to bind with high affinity receptors selectively
expressed on cell membranes of different human tissues, represent valuable tools for in vivo …

Development of alternative HPLC method for determination of tirofiban in rat serum

M Darkovska-Serafimovska… - Macedonian Journal of …, 2016 - mjcce.org.mk
Tirofiban hydrochloride is a reversible antagonist of fibrinogen binding to the GPIIb/IIIa
receptor, used for the treatment of acute coronary syndrome. A novel RP-HPLC method has …

Radiolabeled tirofiban–a potential radiopharmaceutical for detection of deep venous thrombosis

M Darkovska-Serafimovska… - Drug Design …, 2016 - Taylor & Francis
Aim The aim of this study was to investigate the possibility of using 99mtechnetium (99mTc)-
labeled tirofiban (a reversible antagonist of glycoprotein IIb/IIIa) for detection of deep venous …

Tirofiban kao potencijalni radiofarmaceutik za detekciju tromboembolijskih poremećaja: animalni model

M Darkovska-Serafimovska - 2016 - search.proquest.com
Vaskularna oboljenja spadaju među vodeće uzročnike povećanog morbiditeta i mortaliteta
kod ljudi koji žive u razvijenim zemljama. Duboka venska tromboza (DVT) i plućna embolija …